Coeptis Therapeutics Holdings, Inc. COEP
10.99 USD 0.00 (+0.00%)
Jul 2, 2026, 3:59 PM EDT
10.81 Day range 11.99
52-week range unavailable
- YTD
- -22.88%
- 1 year
- -11.87%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.36M | 0 | 0 | 0 | 75.00K | |
| 1.18M | 0 | 0 | 0 | 75.00K | |
| -13.04M | -10.05M | -21.49M | -34.20M | -14.05M | |
| -11.92M | -10.68M | 0 | -37.57M | -13.45M | |
| -2.81 | -5.56 | -16.56 | -53.00 | -24.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.67M | 532.88K | 1.47M | 3.79M | 2.18M | |
| 16.15M | 8.91M | 4.57M | 7.92M | 6.77M | |
| 2.09M | 5.04M | 3.76M | 3.46M | 4.41M | |
| 268.88K | 1.40M | 1.22M | 2.06M | 4.08M | |
| 13.56M | 3.38M | 813.96K | 4.45M | 2.35M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -8.60M | -6.65M | -7.24M | -3.88M | -4.49M | |
| 13.74M | 5.71M | 4.92M | 5.49M | 8.22M | |
| 5.14M | -936.25K | -2.32M | 1.61M | 1.98M |